Docoh
Loading...

Fisher Wallace Laboratories

Filed: 30 Apr 21, 6:05am
schemaVersion:

Form C: Filer Information

Filer CIK:
0001787792
Filer CCC:
XXXXXXXX
Period:

12-31-2020

Is this a LIVE or TEST Filing?Radio button checked LIVE Radio button not checked TEST
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?Checkbox not checked
Would you like a Return Copy?Checkbox not checked

Submission Contact Information

Name:
Phone Number:
Contact E-Mail Address:
Notify via Filing Website only?Checkbox not checked

Form C: Issuer Information

Issuer Information

Name of Issuer:

Fisher Wallace Laboratories, Inc.

Legal Status of Issuer:

Form:

Corporation

Jurisdiction of Incorporation/Organization:

DELAWARE

Date of Incorporation/Organization:

08-13-2019

Physical Address of Issuer:

Address 1:

325 Rutledge Street

City:

Brooklyn

State/Country:

NEW YORK

Mailing Zip/Postal Code:

11211

Website of Issuer:

www.fisherwallace.com

Form C: Offering Information

Offering Information

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:

6.00

Total Assets Most Recent Fiscal Year-end:

853359.00

Total Assets Prior Fiscal Year-end:

390878.00

Cash and Cash Equivalents Most Recent Fiscal Year-end:

695749.00

Cash and Cash Equivalents Prior Fiscal Year-end:

339584.00

Accounts Receivable Most Recent Fiscal Year-end:

2302.00

Accounts Receivable Prior Fiscal Year-end:

30560.00

Short-term Debt Most Recent Fiscal Year-end:

704412.00

Short-term Debt Prior Fiscal Year-end:

0.00

Long-term Debt Most Recent Fiscal Year-end:

641126.00

Long-term Debt Prior Fiscal Year-end:

625525.00

Revenue/Sales Most Recent Fiscal Year-end:

4250866.00

Revenue/Sales Prior Fiscal Year-end:

3864706.00

Cost of Goods Sold Most Recent Fiscal Year-end:

970761.00

Cost of Goods Sold Prior Fiscal Year-end:

947495.00

Taxes Paid Most Recent Fiscal Year-end:

1597.00

Taxes Paid Prior Fiscal Year-end:

0.00

Net Income Most Recent Fiscal Year-end:

-1823732.00

Net Income Prior Fiscal Year-end:

-543056.00

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:

Fisher Wallace Laboratories, Inc.

Signature:

/s/ Kelly Roman

Title:

Chief Executive Officer

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Kelly Roman

Title:

Chief Executive Officer

Date:

04-30-2021